$6.87
6.91%
Nasdaq, Oct 16, 04:32 pm EDT. Closed.
Why the stock moved Why the stock moved Beta
ISIN
US67576A1007
Symbol
OCUL

Ocular Therapeutix Inc Target price 2026 - Analyst rating & recommendation

Ocular Therapeutix Inc Classifications & Recommendation

Buy
94%
Hold
6%

Ocular Therapeutix Inc Price Target

Target Price $28.56
Price $6.87
Potential
Number of Estimates 13
13 Analysts have issued a price target Ocular Therapeutix Inc 2027 . The average Ocular Therapeutix Inc target price is $28.56. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 18 analysts: 17 Analysts recommend Ocular Therapeutix Inc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ocular Therapeutix Inc stock has an average upside potential 2027 of . Most analysts recommend the Ocular Therapeutix Inc stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

14 Analysts have issued a sales forecast Ocular Therapeutix Inc 2026 . The average Ocular Therapeutix Inc sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 $52.0m 18.47%
2026
2027
2028
2029
2030
2031
2032
2033

4 Analysts have issued an Ocular Therapeutix Inc EBITDA forecast 2026. The average Ocular Therapeutix Inc EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-266m 58.15%
2026
2027
2028
2029
2030
2031
2032
2033

EBITDA Margin

2025 -511.43% 93.98%
2026
2027
2028
2029
2030
2031
2032
2033

14 Ocular Therapeutix Inc Analysts have issued a net profit forecast 2026. The average Ocular Therapeutix Inc net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-266m 37.43%
2026
2027
2028
2029
2030
2031
2032
2033

Net Margin

2025 -511.92% 68.57%
2026
2027
2028
2029
2030
2031
2032
2033

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ ??? ???
??? ???
P/E ???
EV/Sales ???

14 Analysts have issued a Ocular Therapeutix Inc forecast for earnings per share. The average Ocular Therapeutix Inc EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-1.42 16.39%
2026
2027
2028
2029
2030
2031
2032
2033

P/E ratio

Current -5.13 45.60%
2026
2027
2028
2029
2030
2031
2032
2033

Based on analysts' sales estimates for 2026, the Ocular Therapeutix Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 18.88 50.82%
2026
2027
2028
2029
2030
2031
2032
2033

P/S ratio

Current 28.99 34.21%
2026
2027
2028
2029
2030
2031
2032
2033

Current Ocular Therapeutix Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
Analyst Rating Date
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today